On August 15, 2024, the U.S. Food and Drug Administration (FDA) approved durvalumab (IMFINZI®, AstraZeneca) in combination with platinum-containing chemotherapy…
Browsing: Lung
Lung Cancer
Leading oncologists come together in this recorded live event to discuss targeted therapy options for patients with lung cancer. This…
Leading oncologists come together in this recorded live event to discuss targeted therapy options for patients with lung cancer. This…
Leading oncologists come together in this recorded live event to discuss targeted therapy options for patients with lung cancer. This…
Leading oncologists come together in this recorded live event to discuss targeted therapy options for patients with lung cancer. This…
Leading oncologists come together in this recorded live event to discuss targeted therapy options for patients with lung cancer. This…
Leading oncologists come together in this recorded live event to discuss targeted therapy options for patients with lung cancer. This…
Leading oncologists come together in this recorded live event to discuss targeted therapy options for patients with lung cancer. This…
Leading oncologists come together in this recorded live event to discuss targeted therapy options for patients with lung cancer. This…
Leading oncologists come together in this recorded live event to discuss targeted therapy options for patients with lung cancer. This…
Leading oncologists come together in this recorded live event to discuss targeted therapy options for patients with lung cancer. This…
Leading oncologists come together in this recorded live event to discuss targeted therapy options for patients with lung cancer. This…
Leading oncologists come together in this recorded live event to discuss targeted therapy options for patients with lung cancer. This…
Leading oncologists come together in this recorded live event to discuss targeted therapy options for patients with lung cancer. This…
Leading oncologists come together in this recorded live event to discuss targeted therapy options for patients with lung cancer. This…
Leading oncologists come together in this recorded live event to discuss targeted therapy options for patients with lung cancer. This…
Leading oncologists come together in this recorded live event to discuss targeted therapy options for patients with lung cancer. This…
Leading oncologists come together in this recorded live event to discuss targeted therapy options for patients with lung cancer. This…
Leading oncologists come together in this recorded live event to discuss targeted therapy options for patients with lung cancer. This…
Leading oncologists come together in this recorded live event to discuss targeted therapy options for patients with lung cancer. This…
Leading oncologists come together in this recorded live event to discuss targeted therapy options for patients with lung cancer. This…
Leading oncologists come together in this recorded live event to discuss targeted therapy options for patients with lung cancer. This…
Leading oncologists come together in this recorded live event to discuss targeted therapy options for patients with lung cancer. This…
Leading oncologists come together in this recorded live event to discuss targeted therapy options for patients with lung cancer. This…
Leading oncologists come together in this recorded live event to discuss targeted therapy options for patients with lung cancer. This…
Leading oncologists come together in this recorded live event to discuss targeted therapy options for patients with lung cancer. This…
Leading oncologists come together in this recorded live event to discuss targeted therapy options for patients with lung cancer. This…
Leading oncologists come together in this recorded live event to discuss targeted therapy options for patients with lung cancer. This…
Leading oncologists come together in this recorded live event to discuss targeted therapy options for patients with lung cancer. This…
Leading oncologists come together in this recorded live event to discuss targeted therapy options for patients with lung cancer. This…
Leading oncologists come together in this recorded live event to discuss targeted therapy options for patients with lung cancer. This…
Leading oncologists come together in this recorded live event to discuss targeted therapy options for patients with lung cancer. This…
Leading oncologists come together in this recorded live event to discuss targeted therapy options for patients with lung cancer. This…
Leading oncologists come together in this recorded live event to discuss targeted therapy options for patients with lung cancer. This…
Leading oncologists come together in this recorded live event to discuss targeted therapy options for patients with lung cancer. This…
Leading oncologists come together in this recorded live event to discuss targeted therapy options for patients with lung cancer. This…
Leading oncologists come together in this recorded live event to discuss targeted therapy options for patients with lung cancer. This…
Leading oncologists come together in this recorded live event to discuss targeted therapy options for patients with lung cancer. This…
The full video from the Spanish Targeted Therapies in Lung Cancer Patient Forum 2023 is available now to view ONDemand,…
Leading oncologists come together in this recorded live event to discuss targeted therapy options for patients with lung cancer. This…
Leading oncologists come together in this recorded live event to discuss targeted therapy options for patients with lung cancer. This…
Leading oncologists come together in this recorded live event to discuss targeted therapy options for patients with lung cancer. This…
This full unedited version of the 2023 Targeted Therapies in Lung Cancer Patient Forum presentations from the Mainstage, on Saturday,…
This full unedited version of the 2023 Targeted Therapies in Lung Cancer Patient Forum presentations from the Mainstage, on Saturday,…
Author: Dr Antonio Passaro (on-camera comments) – Courtesy of ESMO.org At the ESMO 2023 conference, the results of the Phase three…
Author: Professor Ben Solomon (on-camera comments) – Courtesy of ESMO.org At ESMO 2023, the speaker had the pleasure of presenting the…
For this year’s post-ASCO Lung Cancer panel discussion, Drs. H.Jack West, Oncologist with City of Hope Comprehensive Cancer Center, and…
For this year’s post-ASCO Lung Cancer panel discussion, Drs. H.Jack West, Oncologist with City of Hope Comprehensive Cancer Center, and…
Lung cancer screening has emerged as an essential tool in identifying the disease at its early stages, when it is…
Dr. Jack West, MD, an associate professor in medical oncology focused on thoracic oncology at the City of Hope Comprehensive…
In ASCO 2023, the highly anticipated results of the Adora study were unveiled, providing valuable insights into the efficacy and impact…
Sotorasib, as demonstrated by the CodeBreaK 200 study, is a promising treatment for patients with KRAS G12C-mutated advanced NSCLC, with…
Caicun Zhou, MD, PhD – Tongji University Shanghai Pulmonary Hospital Sunvozertinib established itself as the leading targeted therapy for NSCLC…
Ferdinandos Skoulidis, MD, PhD, from the MD Anderson Cancer Center, presented the results of biomarker subgroup analyses from the phase…
Dr. Atulya Khosla discussed the “Saved by the Scan” public service advertising program initiated by the American Lung Association (ALA)…
iFrame is not supported! Lung Cancer: My Top 5 Abstracts to See in Lung Cancer at ASCO 2023 Jack West…
Lung Cancer: My Top 5 Abstracts to See in Lung Cancer at ASCO 2023 By Jack West, MD, associate professor…
Lung Cancer EGFR: What Are The Latest Advanced Treatments in 2023? Insights from Ravi Salgia MD By Ravi Salgia, MD,…
Lung Cancer Trials: Insights into Latest Clinical Trials in Thoracic Oncology – Expert Analysis from Ravi Salgia, MD By Ravi…
AI Risk Assessment: Sybil A Reliable Deep Learning Model for Predicting Future Lung Cancer Risk Dr. Florian Fintelmann By Florian…
iFrame is not supported! AI Risk Assessment: Sybil A Reliable Deep Learning Model for Predicting Future Lung Cancer Risk Dr.…
Lung Cancer Screening Program: Cedars-Sinai Implements a Streamlined Approach by Sara Ghandehari MD Sara Ghandehari, MD Cedars-Sinai is a non-profit…
AI Risk Assessment: Sybil A Reliable Deep Learning Model for Predicting Future Lung Cancer Risk Dr. Florian Fintelmann By Florian…
iFrame is not supported! Lung Cancer Screening Program: Cedars-Sinai Implements a Streamlined Approach by Sara Ghandehari MD Sara Ghandehari, MD…
Lung Cancer Screening Program: Cedars-Sinai Implements a Streamlined Approach by Sara Ghandehari MD Sara Ghandehari, MD Cedars-Sinai is a non-profit…
For this 2022 Program: Testing and Early Diagnosis, Drs. Devika Das, Medical Oncologist, Hematologist, UAB Medicine, Clinical Assistant Professor, University…
For this 2022 Program: Testing and Early Diagnosis, Drs. Devika Das, Medical Oncologist, Hematologist, UAB Medicine, Clinical Assistant Professor, University…
For this 2022 Program: Testing and Early Diagnosis, Drs. Devika Das, Medical Oncologist, Hematologist, UAB Medicine, Clinical Assistant Professor, University…
For this 2022 Program: Testing and Early Diagnosis, Drs. Devika Das, Medical Oncologist, Hematologist, UAB Medicine, Clinical Assistant Professor, University…
For this 2022 Program: Testing and Early Diagnosis, Drs. Devika Das, Medical Oncologist, Hematologist, UAB Medicine, Clinical Assistant Professor, University…
For this 2022 Program: Testing and Early Diagnosis, Drs. Devika Das, Medical Oncologist, Hematologist, UAB Medicine, Clinical Assistant Professor, University…
For this 2022 Program: Testing and Early Diagnosis, Drs. Devika Das, Medical Oncologist, Hematologist, UAB Medicine, Clinical Assistant Professor, University…
For our Mandarin-speaking community, GRACE is happy to offer updates to our Lung Cancer Video Library translated and voiced by…
For our Mandarin-speaking community, GRACE is happy to offer updates to our Lung Cancer Video Library translated and voiced by…
iFrame is not supported! LCMC3 Neoadjuvant Atezolizumab Phase 2 Study Results What is the LCMC3 (Lung Cancer Mutation Consortium)…
LCMC3 Neoadjuvant Atezolizumab Phase 2 Study Results What is the LCMC3 (Lung Cancer Mutation Consortium) Trial? So, this is…
iFrame is not supported! Is Interstitial Lung Disease a Manageable Adverse Event of Trastuzumab T-DXd Deruxtecan Treatment? What is Trastuzumab…
With over 55% of cancer patients treated by community oncologists, it’s imperative that community oncologists and pathologists apply a multidisciplinary…
ASCO [2022] Lung Cancer In-Depth Slides: MOASC Dr. Misako Nagasaka’s (thoracic oncology) MOASC Presentation on ASCO (Annual Meeting, American…
Question and Answer Session Dr. Misako Nagasaka – ASCO [2022] Lung Cancer In-Depth Slides: MOASC Presentation https://oncologytube.com/v/41320 Misako Nagasaka, MD…
Despite the advances in precision medicine for non-small cell lung cancer (NSCLC), a significant proportion of patients, particularly African American…
Is Interstitial Lung Disease a Manageable Adverse Event of Trastuzumab T-DXd Deruxtecan Treatment? What is Trastuzumab T-DXd? Trastuzumab T-DXd is…
The 2021 Targeted Therapies Patient Forum, presented live-online, featured top oncologists in their field discussing the most current and emerging…
The 2021 Targeted Therapies Patient Forum, presented live-online, featured top oncologists in their field discussing the most current and emerging…
The 2021 Targeted Therapies Patient Forum, presented live-online, featured top oncologists in their field discussing the most current and emerging…
The 2021 Targeted Therapies Patient Forum, presented live-online, featured top oncologists in their field discussing the most current and emerging…
The 2021 Targeted Therapies Patient Forum, presented live-online, featured top oncologists in their field discussing the most current and emerging…
The 2021 Targeted Therapies Patient Forum, presented live-online, featured top oncologists in their field discussing the most current and emerging…
The 2021 Targeted Therapies Patient Forum, presented live-online, featured top oncologists in their field discussing the most current and emerging…
The 2021 Targeted Therapies Patient Forum, presented live-online, featured top oncologists in their field discussing the most current and emerging…
The 2021 Targeted Therapies Patient Forum, presented live-online, featured top oncologists in their field discussing the most current and emerging…
The 2021 Targeted Therapies Patient Forum, presented live-online, featured top oncologists in their field discussing the most current and emerging…
The 2021 Targeted Therapies Patient Forum, presented live-online, featured top oncologists in their field discussing the most current and emerging…
The 2021 Targeted Therapies Patient Forum, presented live-online, featured top oncologists in their field discussing the most current and emerging…
The 2021 Targeted Therapies Patient Forum, presented live-online, featured top oncologists in their field discussing the most current and emerging…
The 2021 Targeted Therapies Patient Forum, presented live-online, featured top oncologists in their field discussing the most current and emerging…
The 2021 Targeted Therapies Patient Forum, presented live-online, featured top oncologists in their field discussing the most current and emerging…
The 2021 Targeted Therapies Patient Forum, presented live-online, featured top oncologists in their field discussing the most current and emerging…
The 2021 Targeted Therapies Patient Forum, presented live-online, featured top oncologists in their field discussing the most current and emerging…
The 2021 Targeted Therapies Patient Forum, presented live-online, featured top oncologists in their field discussing the most current and emerging…
The 2021 Targeted Therapies Patient Forum, presented live-online, featured top oncologists in their field discussing the most current and emerging…
The 2021 Targeted Therapies Patient Forum, presented live-online, featured top oncologists in their field discussing the most current and emerging…
The 2021 Targeted Therapies Patient Forum, presented live-online, featured top oncologists in their field discussing the most current and emerging…
The 2021 Targeted Therapies Patient Forum, presented live-online, featured top oncologists in their field discussing the most current and emerging…
OncTalk 2021, a live-online, patient education event featured top oncologists discussing Early Stage and Advanced Non-Small Cell Lung Cancer. This…
OncTalk 2021, a live-online, patient education event featured top oncologists discussing Early Stage and Advanced Non-Small Cell Lung Cancer. This…
OncTalk 2021, a live-online, patient education event featured top oncologists discussing Early Stage and Advanced Non-Small Cell Lung Cancer. This…
OncTalk 2021, a live-online, patient education event featured top oncologists discussing Early Stage and Advanced Non-Small Cell Lung Cancer. This…
OncTalk 2021, a live-online, patient education event featured top oncologists discussing Early Stage and Advanced Non-Small Cell Lung Cancer. This…
OncTalk 2021, a live-online, patient education event featured top oncologists discussing Early Stage and Advanced Non-Small Cell Lung Cancer. This…
OncTalk 2021, a live-online, patient education event featured top oncologists discussing Early Stage and Advanced Non-Small Cell Lung Cancer. This…
OncTalk 2021, a live-online, patient education event featured top oncologists discussing Early Stage and Advanced Non-Small Cell Lung Cancer. This…
OncTalk 2021, a live-online, patient education event featured top oncologists discussing Early Stage and Advanced Non-Small Cell Lung Cancer. This…
OncTalk 2021, a live-online, patient education event featured top oncologists discussing Early Stage and Advanced Non-Small Cell Lung Cancer. This…
OncTalk 2021, a live-online, patient education event featured top oncologists discussing Early Stage and Advanced Non-Small Cell Lung Cancer. This…
Raja M. Flores, MD, Professor and System Chair, Thoracic Surgery at Icahn School of Medicine at Mount Sinai. In this…
Raja M. Flores, MD, Professor and System Chair, Thoracic Surgery at Icahn School of Medicine at Mount Sinai. In this…
Debra Dyer, MD, FACR, Professor, a radiologist at National Jewish Health. Dr. Dyer serves as Chair of the Department of…
Debra Dyer, MD, FACR, Professor, a radiologist at National Jewish Health. Dr. Dyer serves as Chair of the Department of…
Christopher Cann, MD, Clinical Fellow, Division of Hematology/Oncology, Department of Medicine at Vanderbilt University Medical Center. In this video, he…
Christopher Cann, MD, Clinical Fellow, Division of Hematology/Oncology, Department of Medicine at Vanderbilt University Medical Center. In this video, he…
Matthew Smeltzer, Ph.D., MStat, Associate Professor, Division of Epidemiology, Biostatistics, and Environmental Health at the University of Memphis. Dr. Smeltzer…
Matthew Smeltzer, Ph.D., MStat, Associate Professor, Division of Epidemiology, Biostatistics, and Environmental Health at the University of Memphis. Dr. Smeltzer…
Toni Choueiri, MD, Director, Lank Center for Genitourinary Oncology, Director, Kidney Cancer Center, Senior Physician, Jerome and Nancy Kohlberg Chair…
Toni Choueiri, MD, Director, Lank Center for Genitourinary Oncology, Director, Kidney Cancer Center, Senior Physician, Jerome and Nancy Kohlberg Chair…
Miguel Garcia, MD, Clinical Research Fellow, Division of Medical Oncology & Hematology at University Health Network. In this video, he…
Miguel Garcia, MD, Clinical Research Fellow, Division of Medical Oncology & Hematology at University Health Network. In this video, he…
Christian Rolfo, MD, Ph.D., MBA, Dr.hc., Professor of Medicine (Hematology and Medical Oncology) and Associate Director for Clinical Research in…
Christian Rolfo, MD, Ph.D., MBA, Dr.hc., Professor of Medicine (Hematology and Medical Oncology) and Associate Director for Clinical Research in…
Drs. H. Jack West, Joan Schiller, and Isabel Preeshagul gathered (virtually) to review information presented at ASCO and ESMO for…
Drs. H. Jack West, Joan Schiller, and Isabel Preeshagul gathered (virtually) to review information presented at ASCO and ESMO for…
Drs. H. Jack West, Joan Schiller, and Isabel Preeshagul gathered (virtually) to review information presented at ASCO and ESMO for…
Drs. H. Jack West, Joan Schiller, and Isabel Preeshagul gathered (virtually) to review information presented at ASCO and ESMO for…
Drs. H. Jack West, Joan Schiller, and Isabel Preeshagul gathered (virtually) to review information presented at ASCO and ESMO for…
Drs. H. Jack West, Joan Schiller, and Isabel Preeshagul gathered (virtually) to review information presented at ASCO and ESMO for…
Drs. H. Jack West, Joan Schiller, and Isabel Preeshagul gathered (virtually) to review information presented at ASCO and ESMO for…
Drs. H. Jack West, Joan Schiller, and Isabel Preeshagul gathered (virtually) to review information presented at ASCO and ESMO for…
Drs. H. Jack West, Joan Schiller, and Isabel Preeshagul gathered (virtually) to review information presented at ASCO and ESMO for…
Drs. H. Jack West, Joan Schiller, and Isabel Preeshagul gathered (virtually) to review information presented at ASCO and ESMO for…
Drs. H. Jack West, Joan Schiller, and Isabel Preeshagul gathered (virtually) to review information presented at ASCO and ESMO for…
Drs. H. Jack West, Joan Schiller, and Isabel Preeshagul gathered (virtually) to review information presented at ASCO and ESMO for…
¡El video completo del Foro de Pacientes de Terapias Dirigidas 2021, presentado en español, ya está disponible! Este foro en…
Geoffrey B. Pelz, MD, Thoracic Surgical Oncology, Hackensack Meridian Health speaks about the New GPS-Like Technology to Detect & Help…
Geoffrey B. Pelz, MD, Thoracic Surgical Oncology, Hackensack Meridian Health speaks about the New GPS-Like Technology to Detect & Help…
Carla R. Lamb, MD an interventional pulmonologist at Lahey Hospital & Medical Center speaks about Veracyte Announces New Expanded Data…
Carla R. Lamb, MD an interventional pulmonologist at Lahey Hospital and Medical Center speaks about Veracyte Announces New Expanded Data…
Amy Moore, Ph.D., VP, Global Engagement and Patient Partnerships at LUNGevity Foundation speaks about LUNGevity Foundation Launches New Lung Cancer…
Amy Moore, Ph.D., VP, Global Engagement and Patient Partnerships at LUNGevity Foundation speaks about LUNGevity Foundation Launches New Lung Cancer…
Howard ‘Jack’ West, MD, Executive Director of Employer Strategy; Associate Clinical Professor, Department of Medical Oncology and; Therapeutics Research at…
Howard ‘Jack’ West, MD, Executive Director of Employer Strategy; Associate Clinical Professor, Department of Medical Oncology and; Therapeutics Research at…
Howard ‘Jack’ West, MD, Executive Director of Employer Strategy; Associate Clinical Professor, Department of Medical Oncology & Therapeutics Research at…
Robert Seitz, Head of Immune Oncology at Oncocyte speaks about AACR 2021 Abstract: 23 – Validation of a 27-gene immuno-oncology…
Jennifer C. King, Ph.D. CFO of the GO2 Foundation speaks about GO2 Foundation Leads Study to Improve Participation of Black…
Prof. Giorgio Scagliotti Professor of Medical Oncology from the Università di Torino speaks about IASLC Statement on the Updated United…